Drug Companies Ask High Court To Review Actavis Role In Patent, Antitrust Case
WASHINGTON, D.C. — Responding to the U.S. solicitor general’s amicus curiae brief, drug companies argue in an Oct. 19 supplemental brief to the U.S. Supreme Court that they disagree with the...To view the full article, register now.
Already a subscriber? Click here to view full article